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220A The Journal of Thoracic an480 A stepwise model for delivering medical humanitarian aid requiring complex
interventions(continued on page 21A
d Cardiovascular Surgery c December 2014J. Nilas Young, MD, Josie Everett, BA, Janet M. Simsic, MD, Nathaniel W. Taggart, MD,
Sonny Bert Litwin, MD, Natalia Lusin, PhD, Lizbeth Hasse, Esq, JD, Evgeny V. Krivoshchekov, MD,
James P. Marcin, MD, MPH, Gary W. Raff, MD, and Frank Cetta, MD, Sacramento, Oakland, and
San Francisco, Calif; Columbus, Ohio; Rochester, Minn; Milwaukee, Wis; and Tomsk, RussiaA proven model for successful international congenital cardiac surgical outreach that focuses on
education, clinical excellence, sustainability, and scalability, which has evolved over a 25-year
period and has been applied in multiple geographic sites, is described.Editorial Commentary 2489 Humanitarian congenital heart surgery: Template for success
Carl Lewis Backer, MD, Chicago, Ill2491 Training less-experienced faculty improves reliability of skills assessment in
cardiac surgery
Xiaoying Lou, BS, Richard Lee, MD, Richard H. Feins, MD, Daniel Enter, MD,
George L. Hicks, Jr, MD, Edward D. Verrier, MD, and James I. Fann, MD, Chicago, Ill, St Louis,
Mo, Chapel Hill, NC, Rochester, NY, Seattle, Wash, and Stanford, CalifInter-rater reliability in the assessment of simulated coronary anastomoses was evaluated among
less-experienced faculty at the TSDA Boot Camp. Brief but focused anchor training improved
inter-rater reliability for composite scores and multiple assessment components. Such training may
be needed before objective evaluation of technical skills in cardiac surgery.Editorial Commentary 2497 Technical skills assessment in thoracic surgery education: We won’t get fooled
again
Marc R. Moon, MD, St Louis, MoCongenital Heart
Disease (CHD)
2499 Outcomes of cardiac surgery in patients weighing ,2.5 kg: Affect of
patient-dependent and -independent variables
David Kalfa, MD, PhD, Ganga Krishnamurthy, MD, Jennifer Duchon, MD, Marc Najjar, MD,
Stephanie Levasseur, MD, Paul Chai, MD, Jonathan Chen, MD, Jan Quaegebeur, MD, PhD, and
Emile Bacha, MD, New York, NY, and Seattle, WashAlthough a weight of ,2.5 kg at surgery remains a risk factor for early mortality, a dedicated
neonatal cardiac program can yield good early and late outcomes for low-weight neonates and
infants, independently of the STAT risk category. A lower gestational age was an independent risk
factor for early mortality.Editorial Commentary 2506 Timing is even more important than we thought! The effect of gestational age
versus body weight on outcomes of neonatal heart surgery
Osman O. Al-Radi, MD, MSc, FRCSC, Jeddah, Saudi Arabia)
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L2508 Low-weight infants are at increased mortality risk after palliative or corrective
cardiac surgery(continued on page 22A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 6 21AEBahaaldin Alsoufi, MD, Cedric Manlhiot, BSc, William T. Mahle, MD, Brian Kogon, MD,
William L. Border, MBChB, MPH, Angel Cuadrado, MD, Robert Vincent, MD,
Brian W. McCrindle, MD, MPH, and Kirk Kanter, MD, Atlanta, Ga, and Toronto, Ontario, CanadaED
UAnalysis of early and late outcomes after infant cardiac surgery showed that low weight (#2.5 kg)
at time of surgery was associated with increased resource utilization and hospital and late mortality
in all patient subgroups with a prolonged death hazard indicating need for improvement in both
perioperative and long-term care.Editorial Commentary 2515 Palliative and corrective surgery in low-weight infants is associated with an
increased mortality risk: How can we do better?DPetros V. Anagnostopoulos, MD, Madison, Wis2517 The modern Fontan operation shows no increase in mortality out to 20 years:
A new paradigmCHRobert J. Dabal, MD, James K. Kirklin, MD, Manisha Kukreja, MBBS, MPH, Robert N. Brown, BS,
David C. Cleveland, MD, Michael C. Eddins, MD, and Yung Lau, MD, Birmingham, AlaSAnalysis of a 24-year experience with the Fontan procedure using a polytetrafluoroethylene tube
demonstrated a 77% 20-year survival with no late phase of increasing hazard. Late reoperations and
thrombotic complications were rare.TEditorial Commentary 2525 Closing in on the perfect FontanGHarold M. Burkhart, MD, Oklahoma City, Okla2526 Contemporary outcomes of complete atrioventricular septal defect repair:
Analysis of the Society of Thoracic Surgeons Congenital Heart Surgery
DatabaseA
CDJames D. St. Louis, MD, Upinder Jodhka, MD, MHS, Jeffrey P. Jacobs, MD, Xia He, MS,
Kevin D. Hill, MD, Sara K. Pasquali, MD, MHS, and Marshall L. Jacobs, MD, Minneapolis, Minn,
Baltimore, Md, Durham, NC, and Ann Arbor, MichContemporary outcomes data for complete atrioventricular septal defect repair are limited. This
study retrospectively reviewed 2399 patients who underwent repair of a complete atrioventricular
septal defect. Although overall hospital morality was low, the extremes of low weight and age at
repair were associated with worse outcomes.2M
532 Persistent fenestration may be a marker for physiologic intolerance after
Fontan completion
PYasuhiro Kotani, MD, PhD, Devin Chetan, HBA, Arezou Saedi, MD, Jiaquan Zhu, MD, PhD,
Lars Grosse-Wortmann, MD, John G. Coles, MD, Christopher A. Caldarone, MD,
Glen S. Van Arsdell, MD, and Osami Honjo, MD, PhD, Toronto, Ontario, CanadaSThe inability to close a fenestration was a marker for higher mortality and a higher incidence of
Fontan failure/complications. Preoperative assessment including pulmonary artery pressure did not
predict worse outcomes, hence routine creation of fenestration and subsequent assessment for
catheter-based closure still seems to be a reasonable strategy./B)
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SEditorial Commentary 222A The Journal of Thoracic an538 To fenestrate or not: The Fontan debate gets more complicated(continued on page 23A
d Cardiovascular Surgery c December 2014Charles D. Fraser, Jr, MD, Houston, Tex2540 Outcomes differ in patients who undergo immediate intraoperative revision
versus patients with delayed postoperative revision of residual lesions in
congenital heart operations
Meena Nathan, MD, Kimberlee Gauvreau, ScD, Hua Liu, MS, Frank A. Pigula, MD,
John E. Mayer, MD, Steven D. Colan, MD, and Pedro J. del Nido, MD, Boston, MassIntraoperative correction of residual lesions results in lower adverse event rates and lower resource
use as measured by postoperative hospital length of stay, compared with postoperative revision of
such lesions in congenital cardiac procedures.Editorial Commentary 2548 Management of residual lesions following surgery for congenital heart defects:
Evidence versus judgment
Christian Pizarro, MD, Wilmington, Del2550 Losartan ameliorates ‘‘upstream’’ pulmonary vein vasculopathy in a piglet
model of pulmonary vein stenosis
Jiaquan Zhu, MD, PhD, Haruki Ide, MD, Yaqin Yana Fu, MD, Anouk-Martine Teichert, PhD,
Hideyuki Kato, MD, Richard D. Weisel, MD, Jason T. Maynes, MD, PhD, John G. Coles, MD, and
Christopher A. Caldarone, MD, Toronto, Ontario, CanadaLosartan slowed the progression of upstream pulmonary vein vasculopathy in a piglet model of
pulmonary vein stenosis.Editorial Commentary 2559 Losartan for progressive pulmonary vein stenosis: A possible solution?
Paul J. Chai, MD, New York, NY2560 Validation of association of the apolipoprotein E 32 allele with
neurodevelopmental dysfunction after cardiac surgery in neonates and
infants
J. William Gaynor, MD, Daniel Seung Kim, BS, Cammon B. Arrington, MD, PhD,
Andrew M. Atz, MD, David C. Bellinger, PhD, Amber A. Burt, MSPH, Nancy S. Ghanayem, MD,
Jeffery P. Jacobs, MD, Teresa M. Lee, MD, Alan B. Lewis, MD, William T. Mahle, MD,
Bradley S. Marino, MD, Stephen G. Miller, MD, Jane W. Newburger, MD, MPH,
Christian Pizarro, MD, Chitra Ravishankar, MD, Avni B. Santani, PhD, Nicole S. Wilder, MD,
Gail P. Jarvik, MD, PhD, Seema Mital, MD, and Mark W. Russell, MD, Philadelphia, Pa, Seattle,
Wash, Salt Lake City, Utah, Charleston, SC, Boston, Mass, Milwaukee, Wis, St Petersburg, Fla,
New York, NY, Los Angeles, Calif, Atlanta, Ga, Cincinnati, Ohio, Durham, NC, Wilmington, Del,
Ann Arbor, Mich, and Toronto, Ontario, CanadaThis study validates the previously reported association of the APOE ε2 allele with adverse
neurodevelopmental outcomes after cardiac surgery in infants, independent of patient and operative
factors. Genetic variants that decrease neuroresilience and impair neuronal repair after brain injury
are important risk factors for neurodevelopmental dysfunction after surgery for CHD.Editorial Commentary 2568 Validation accepted, but look at what else was revealed
Erle H. Austin III, MD, Louisville, Ky)
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L2570 Unidirectional valved patch closure of ventricular septal defects with severe
pulmonary arterial hypertension: Hemodynamic outcomes(continued on page 24A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 6 23AE
D
USachin Talwar, MCh, Vikas Kumar Keshri, MS, Shiv Kumar Choudhary, MCh,
Saurabh Kumar Gupta, DM, Sivasubramanian Ramakrishnan, DM, Anita Saxena, DM,
Shyam Sunder Kothari, DM, Rajnish Juneja, DM, Guresh Kumar, PhD, and Balram Airan, MCh,
New Delhi, IndiaEOf 20 patients with a VSD and severe PAH, 13 underwent follow-up cardiac catheterization 2 to
56 months after VSD closure with a UVP. The PVRI had decreased significantly to 5.86 2.1Wood
units (P 5 .02), with a significant decrease in the pulmonary artery systolic, diastolic, and mean
pressures.2576 A simple surgical technique for closure of apical muscular ventricular septal
defectH
DCAmit Mishra, MCh, FPCS, Ritesh Shah, MD, Manan Desai, MCh, Ajay Chourasiya, MCh,
Hardik Patel, MBBS, Nilesh Oswal, MD, and Dayesh Rodricks, DPT, Gujarat, IndiaMultiple apical and apical muscular ventricular septal defects are a common surgical problem
encountered in pediatric cardiac clinics. We present our experience of closing these defects using
our custom-made single disc low-profile polytetrafluoroethylene device.2TS580 Increased common atrioventricular valve tenting is a risk factor for
progression to severe regurgitation in patients with a single ventricle with
unbalanced atrioventricular septal defectGChodchanok Vijarnsorn, MD, Nee Scze Khoo, MD, Edythe B. Tham, MD, Timothy Colen, MD,
Ivan M. Rebeyka, MD, and Jeffrey F. Smallhorn, MD, Edmonton, Alberta, CanadaDSevere atrioventricular valve regurgitation increases mortality in patients with a single ventricle
with an unbalanced atrioventricular septal defect. Forty-six patients underwent review of their
initial echocardiography showing early leaflet tethering (increased tenting height to common valve)
to predict subsequent AVV failure. This may represent an important adaptive process to maintain
valve competency in unbalanced atrioventricular septal defects.C2589 Factors associated with right ventricular dilatation and dysfunction in patients
with chronic pulmonary regurgitation after repair of tetralogy of Fallot:
Analysis of magnetic resonance imaging data from 218 patientsACheul Lee, MD, PhD, Chang-Ha Lee, MD, Jae Gun Kwak, MD, Seong-Ho Kim, MD,
Woo-Sup Shim, MD, Sang Yun Lee, MD, So-Ick Jang, MD, Su-Jin Park, MD, and
Yang Min Kim, MD, Bucheon, Republic of KoreaPM
A total of 218 patients with repaired TOF underwent MRI. Male sex, VSD closure through the right
ventricle, longer interval since repair, and greater PR fraction were independent predictors of RV
dilatation. Male sex, VSD closure through the right ventricle, and greater PR fraction were also
independent predictors for RV dysfunction.2597 Early and midterm outcomes of left pulmonary artery angioplasty using an
anterior wall flap of the main pulmonary artery in tetralogy of Fallot repair
Hyungtae Kim, MD, Si Chan Sung, MD, Yun Hee Chang, MD, Hyoung Doo Lee, MD, and
Ji Ae Park, MD, Gyeongsangnam-do and Seoul, Republic of KoreaT/
B
SEAngioplasty of the proximal LPA using an anterior wall flap of the MPA in patients with TOF and
pulmonary stenosis is an effective method in the management of acute angle and/or stenosis of the
LPAwithout postoperative kinking.)
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S224A The Journal of Thoracic an602 Successful surgical management of ventricular fibromas in children(continued on page 25A
d Cardiovascular Surgery c December 2014Meena Nathan, MD, Assunta Fabozzo, MD, Tal Geva, MD, Edward Walsh, MD, and
Pedro J. del Nido, MD, Boston, MassVentricular fibromas are rare cardiac tumors predominantly presenting with arrhythmias.
Successful complete or near complete resection is possible in most cases, with relief of arrhythmia
and preservation of ventricular function.2609 Ventricular and pulmonary vascular remodeling induced by pulmonary
overflow in a chronic model of pretricuspid shunt
Daniele Linardi, MD, Alessio Rungatscher, MD, PhD, FAHA, Mohammed Morjan, MD,
Paolo Marino, MD, Giovanni Battista Luciani, MD, Alessandro Mazzucco, MD, and
Giuseppe Faggian, MD, Verona and Novara, ItalyAn aortocaval shunt was created in rats. The chronic effects were evaluated using biventricular
catheterization, echocardiography, magnetic resonance, and histology after 10 and 20 weeks. The
aortocaval shunt is a reliable model to produce right ventricular volume overload and secondary
pulmonary hypertension similar to chronic atrial-level shunt.2618 Surgery for simple and complex subaortic stenosis in children and young
adults: Results from a prospective, procedure-based national database
Dan M. Dorobantu, MBBS, Mansour T. Sharabiani, PhD, Robin P. Martin, FRCP,
Gianni D. Angelini, FRCS, Andrew J. Parry, FRCS, Massimo Caputo, MD, and
Serban C. Stoica, FRCS, Bristol and London, United Kingdom; and Chicago, IllIn a national population of 1047 consecutive children and young adults, simple and complex SAS
was treated with an overall early mortality of 1.6%. The long-term results were good but complex
forms of the disease had less favorable survival and freedom from reintervention.2627 Ventriculovascular interactions late after atrial and arterial repair of
transposition of the great arteries
Giovanni Biglino, PhD, Hopewell Ntsinjana, MD, Carla Plymen, MD, Oliver Tann, MD,
Alessandro Giardini, MD, Graham Derrick, MD, Kim H. Parker, PhD, Victor Tsang, MD,
Silvia Schievano, PhD, and Andrew M. Taylor, MD, PhD, London, United KingdomThis study uses wave intensity analysis derived from cardiovascular magnetic resonance imaging to
investigate ventriculovascular interactions in repaired transposition of the great arteries. Reduced
aortic distensibility and compromised coupling were observed. An intraoperational difference
(atrial redirection vs arterial switch operation) was noted, likely reflecting the different nature of the
subaortic ventricle.2634 Skeletal muscle and plasma concentrations of cefazolin during cardiac surgery
in infants
Adam S. Himebauch, MD, Susan C. Nicolson, MD, Martha Sisko, BSN, RN, MS, CCRC,
Ganesh Moorthy, PhD, Stephanie Fuller, MD, J. William Gaynor, MD,
Athena F. Zuppa, MD, MSCE, Elizabeth Fox, MD, and Todd J. Kilbaugh, MD, Philadelphia, PaUnbound plasma and skeletal muscle cefazolin concentrations were measured after prophylactic
cefazolin administration during open cardiac surgery. The achieved skeletal muscle concentrations
are likely effective against methicillin-sensitive S aureus but might not be effective against other
pathogens causing surgical site infections in this population.)
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L2642 Should early extubation be the goal for children after congenital cardiac
surgery?(continued on page 26A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 6 25AEKevin C. Harris, MD, MHSc, Spencer Holowachuk, BHK, Sandy Pitfield, MD,
Shubhayan Sanatani, MD, Norbert Froese, MD, James E. Potts, PhD, and Sanjiv K. Gandhi, MD,
Vancouver, British Columbia, CanadaED
UWe evaluated an EE strategy in 613 children (97 neonates) undergoing congenital heart surgery
using a linked database analysis. EE was achieved in 89% overall (63% of the neonates) and was
associated with excellent clinical outcomes, low complication rates, and short lengths of stay.Editorial Commentary 2649 Who belongs on the ‘‘fast track’’?
Ralph S. Mosca, MD, New York, NYCGeneral Thoracic
Surgery (GTS)
2651 Lung volume reduction surgery since the National Emphysema Treatment
Trial: Study of Society of Thoracic Surgeons DatabaseH
DMarquita R. Decker, MD, MPH, Glen E. Leverson, PhD, Wassim Abi Jaoude, MD, and
James D. Maloney, MD, Madison, WisLung volume reduction surgery is a safe and effective treatment for emphysema in select patients.
This study sought to describe contemporary practice patterns and outcomes of this surgery on a
national level.2G659 Prognostic value of intraoperative pleural lavage cytology for non–small cell
lung cancer: The influence of positive pleural lavage cytology results on
T classificationTSKotaro Kameyama, MD, Norihito Okumura, MD, Etsuo Miyaoka, PhD, Hisao Asamura, MD,
Ichiro Yoshino, MD, Hirohito Tada, MD, Yoshitaka Fujii, MD, Yoichi Nakanishi, MD,
Kenji Eguchi, MD, Masaki Mori, MD, Hideo Kobayashi, MD, Noriyoshi Sawabata, MD,
Meinoshin Okumura, MD, and Kohei Yokoi, MD, for the Japanese Joint Committee of Lung Cancer
Registry, Kurashiki, Tokyo, Chiba, Osaka, Nagoya, Fukuoka, Hokkaido, and Saitama, JapanCD
APleural lavage cytology status was an independent prognostic factor in patients with non–small cell
lung cancer who had been surgically treated. The International Pleural Lavage Cytology
Collaborators recommended that a single increase in the T category up to a maximum of T4 be
assigned to patients with positive pleural lavage cytology results.Editorial Commentary 2665 Intraoperative pleural lavage cytology: More evidence on its prognostic and
staging values
Diego Gonzalez-Rivas, MD, and Ramon Rami-Porta, MD, Coru~na and Barcelona, Spain2667 Autogenous rib grafts for reconstruction of the manubrium after resection:
Technical refinements and outcomesPMGuofei Zhang, MD, Chengxiao Liang, MM, Gang Shen, MD, Wenshan Li, MD, Lijian Huang, MD,
Saibo Pan, MD, and Ying Chai, MD, Hangzhou, China/B
SThere is no consensus concerning the prosthetic material to be used in sternal reconstruction after
resection. We present our experience with autogenous rib grafts for reconstruction of the
manubrium after resection. The technique seems safe and effective, and offers a simple and
satisfactory solution to a complex problem.)
ET
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S226A The Journal of Thoracic an673 Expanded level of sympathetic chain removal does not increase the incidence or
severity of compensatory hyperhidrosis after endoscopic thoracic
sympathectomy(continued on page 27A
d Cardiovascular Surgery c December 2014Tyler M. Gunn, BS, Diane M. Davis, BS, James E. Speicher, MD, Nicholas P. Rossi, MD,
Kalpaj R. Parekh, MD, William R. Lynch, MD, andMark D. Iannettoni, MD, MBA, Iowa City, Iowa,
Ann Arbor, Mich, and Greenville, NCA single-institution, retrospective case review of patients undergoing endoscopic thoracic
sympathectomy for primary hyperhidrosis revealed little difference in outcomes or the incidence of
severe or transient compensatory hyperhidrosis, regardless of the resection extent.Acquired Cardiovascular
Disease (ACD)
2677 Myocardial viability and impact of surgical ventricular reconstruction on
outcomes of patients with severe left ventricular dysfunction undergoing
coronary artery bypass surgery: Results of the Surgical Treatment for Ischemic
Heart Failure trial
Thomas A. Holly, MD, Robert O. Bonow, MD, MS, J. Malcolm O. Arnold, MD, Jae K. Oh, MD,
Padmini Varadarajan, MD, Gerald M. Pohost, MD, Haissam Haddad, MD, Robert H. Jones, MD,
Eric J. Velazquez, MD, Bozena Birkenfeld, MD, Federico M. Asch, MD, Marcin Malinowski, MD,
Rodrigo Barretto, MD, Renato A. K. Kalil, MD, PhD, Daniel S. Berman, MD, Jie-Lena Sun, MS,
Kerry L. Lee, PhD, and Julio A. Panza, MD, Chicago, Ill; London and Ottawa, Ontario, Canada;
Rochester, Minn; Loma Linda and Los Angeles, Calif; Durham, NC; Szczecin and Katowice,
Poland; Washington, DC; Sao Paulo and Porto Alegre, Brazil; and Valhalla, NYIn patients with coronary artery disease and severe regional left ventricular dysfunction, assessment
of myocardial viability by single photon computed tomography does not identify patients who will
derive a mortality benefit from adding surgical ventricular reconstruction to coronary artery bypass
graft surgery.Editorial Commentary 2684 Surgical ventricular restoration, myocardial viability, and your mother’s fine
china
John M. Toole, MD, Charleston, SC2686 The challenge of achieving 1% operative mortality for coronary artery bypass
grafting: A multi-institution Society of Thoracic Surgeons Database analysis
Damien J. LaPar, MD, MSc, Giovanni Filardo, PhD, MPH, Ivan K. Crosby, MD,
Alan M. Speir, MD, Jeffrey B. Rich, MD, Irving L. Kron, MD, and Gorav Ailawadi, MD,
Charlottesville, Falls Church, and Norfolk, Va; and Dallas, TexThis study evaluated the potential to achieving the goal of 1.0% operative mortality for primary,
isolated coronary artery bypass grafting. The results demonstrate that this goal is feasible in
appropriately selected patients. However, this goal may be achieved in only 60% of patients
undergoing coronary artery bypass grafting without other improvements in processes of care.Editorial Commentary 2697 Is a 1% isolated coronary artery bypass grafting mortality really a valid goal?
Richard Lee, MD, MBA, St Louis, Mo)
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L2699 The influence of bilateral internal mammary arteries on short- and long-term
outcomes: A propensity score matching in accordance with current
recommendations(continued on page 28A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 6 27AE
ED
UUmberto Benedetto, MD, PhD, Mohamed Amrani, MD, PhD, FETCS,
Jullien Gaer, MD, FRCS(C-Th), Toufan Bahrami, MD, Fabio de Robertis, MD,
Andre R. Simon, MD, and Shahzad G. Raja, MRCS, FRCS(C-Th), on behalf of the Harefield
Cardiac Outcomes Research Group, London, United KingdomThe present propensity score matching performed in accordance with current recommendations
confirmed that bilateral internal mammary artery use does not increase operative morbidity,
including the risk of deep sternal wound infection and is associated with better long-term outcomes.2706 Guidance for the use of bilateral internal thoracic arteries according to
survival benefit across age groupsH
DCUmberto Benedetto, MD, PhD, Mohamed Amrani, MD, PhD, FETCS, FRCS, and
Shahzad G. Raja, MRCS, FRCS(C-Th), on behalf of the Harefield Cardiac Outcomes Research
Group, London, United KingdomWe demonstrated that the survival benefit from bilateral internal thoracic arteries is dependent on
patient age and identified an age cutoff of 69 years for the loss of survival benefit. Bilateral internal
thoracic artery use should be recommended for patients aged 69 years and younger.2T712 Hypothermia and operative mortality during on-pump coronary artery bypass
graftingS
GKevin L. Greason, MD, Sunghee Kim, Rakesh M. Suri, MD, Amelia S. Wallace, BSPH, and
Brian R. Englum, MD, Durham, NCThe effect of hypothermia during cardiac surgery is controversial. The present study leveraged the
large patient volume in the STS-ACSD to evaluate the effect of hypothermia on mortality in
patients undergoing on-pump CABG. Hypothermia is protective of operative mortality compared
with normothermia in such patients.Editorial Commentary 2718 To cool or not to cool? A
CDJennifer S. Lawton, MD, St Louis, Mo2720 Predictors of contemporary coronary artery bypass grafting outcomesPMRichard D. Weisel, MD, Nancy Nussmeier, MD, Mark F. Newman, MD, Ronald G. Pearl, MD, PhD,
Andrew S. Wechsler, MD, Giuseppe Ambrosio, MD, Bertram Pitt, MD, Robert M. Clare, MS,
Karen S. Pieper, MS, Linda Mongero, CCP, Tammy L. Reece, MS, Terrence M. Yau, MD,
Stephen Fremes, MD, Philippe Menasche, MD, Armando Lira, MD, Robert A. Harrington, MD,
T. Bruce Ferguson,MD, and the RED-CABGExecutive and Steering Committees, Toronto, Ontario,
Canada; Boston, Mass; Durham, NC; Palo Alto, Calif; Philadelphia, Pa; Perugia, Italy; Ann Arbor,
Mich; New York, NY; Paris, France; Basel, Switzerland; and Greenville, NCSThe results of CABG have improved with time, so the RED-CABG trial was used to define the
preoperative and intraoperative risk factors that predict the major adverse events after
contemporary surgery. Adverse outcomes were associated with increased age and a history of heart
failure (even with preserved ejection fraction) or peripheral vascular disease. Preoperative aspirin
was associated with better outcomes./BEditorial Commentary 2727 Coronary artery bypass grafting: Learning to do common things uncommonly
wellETTom C. Nguyen, MD, Houston, Tex)
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S228A The Journal of Thoracic an729 Cost, quality, and value in coronary artery bypass grafting(continued on page 29A
d Cardiovascular Surgery c December 2014Ruben L. Osnabrugge, MSc, Alan M. Speir, MD, Stuart J. Head, PhD, Philip G. Jones, MS,
Gorav Ailawadi, MD, Clifford E. Fonner, BA, Edwin Fonner, Jr, DrPH,
A. Pieter Kappetein, MD, PhD, and Jeffrey B. Rich, MD, Rotterdam, The Netherlands; Fairfax,
Charlottesville, Falls Church, and Norfolk, Va; Kansas City, Mo; and San Mateo, CalifThe Affordable Care Act aims to reduce health care costs by linking valuewithMedicare payments.
We propose a framework, incorporating risk-adjusted measures of resource use and risk-adjusted
morbidity/mortality, that can be used to identify high-value centers for CABG. This framework
provides essential information for quality improvement and pay-for-performance initiatives.2736 Surgery of postinfarction ventricular septal rupture: The effect of David
infarct exclusion versus Daggett direct septal closure on early and late
outcomes
Runar Lundblad, MD, PhD, and Michel Abdelnoor, MPH, PhD, Oslo, NorwayPostinfarction VSR was repaired with the David infarct exclusion (n5 42) or Daggett direct septal
closure (n5 68) technique. The 30-day mortality was lower (16.7% vs 48.5%, P5 .001) and long-
term survival greater (5-year, 69% vs 38%; 10-year, 48% vs 27%; P 5 .004) in the David group.
Total coronary revascularization improved survival more in the David than in the Daggett group.2743 Percutaneous edge-to-edge repair in high-risk and elderly patients with
degenerative mitral regurgitation: Midterm outcomes in a single-center
experience
Maurizio Taramasso, MD, Francesco Maisano, MD, Paolo Denti, MD, Azeem Latib, MD,
Giovanni La Canna, MD, Antonio Colombo, MD, and Ottavio Alfieri, MD, Milan, Italy, and Zurich,
SwitzerlandForty-eight high-risk consecutive patients with severe DMR underwent MitraClip implantation
(mean age, 78.56 10.8 years; mean STS score, 126 10). In-hospital mortality was 2; predischarge
echocardiography showed an MR reduction to grade 2+ or less in 91.5% of patients. Actuarial
survival was 89% 6 5.2%. Significant quality of life improvements were documented. Clinical
benefits also were obtained in octogenarians.Editorial Commentary 2750 Percutaneous edge-to-edge repair for degenerative mitral regurgitation:
A journey to the edge of the bell-shaped curve
Patrick M. McCarthy, MD, Chicago, Ill2752 Left ventricular dysfunction after mitral valve repair—the fallacy of ‘‘normal’’
preoperative myocardial function
Eduard Quintana, MD, Rakesh M. Suri, MD, DPhil, Nassir M. Thalji, MBChB,
Richard C. Daly, MD, Joseph A. Dearani, MD, Harold M. Burkhart, MD, Zhuo Li, MSc,
Maurice Enriquez-Sarano,MD, and Hartzell V. Schaff, MD, Rochester, Minn, and Barcelona, SpainIn patients with a normal EF undergoing mitral valve repair, the incidence, predictors, and
consequences of LV dysfunction after correction of MR are unclear. We have demonstrated that a
greater preoperative pulmonary pressure and greater LV systolic dimension predict for
postoperative LV impairment, which, importantly, can persist and diminish late survival.)
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L2763 Minimally invasive right thoracotomy approach for mitral valve surgery in
patients with previous sternotomy: A single institution experience with 173
patients(continued on page 30A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 6 29AEMichele Murzi, MD, Antonio Miceli, MD, PhD, Gioia Di Stefano, MD, Alfredo G. Cerillo, MD,
Pierandrea Farneti, MD, Marco Solinas, MD, and Mattia Glauber, MD, Massa, ItalyED
UOur study shows that a minimally invasive right chest approach for reoperative mitral valve surgery
can be performed with good early and late results. The avoidance of extensive surgical dissection
and optimal valve exposure are the main advantages of the technique.2769 Outcomes of peripheral perfusion with balloon aortic clamping for totally
endoscopic robotic mitral valve repair
Alison F. Ward, MD, Didier F. Loulmet, MD, Peter J. Neuburger, MD, and Eugene A. Grossi, MD,
New York, NYCH
DA consecutive series of patients underwent TERMR with a primary approach of endoclamping and
retrograde perfusion. Preoperative imaging guided the perfusion strategy; this modified our
approach in several patients. Retrograde perfusion with endoclamping produced excellent
outcomes and permitted routine totally endoscopic mitral valve surgery.2773 Mitral durability after robotic mitral valve repair: Analysis of 200 consecutive
mitral regurgitation repairsTSJae Suk Yoo, MD, Joon Bum Kim, MD, PhD, Sung-Ho Jung, MD, PhD, Dae-Hee Kim, MD, PhD,
Suk Jung Choo,MD, PhD, Cheol Hyun Chung, MD, PhD, and JaeWon Lee, MD, PhD, Seoul, KoreaGThis analysis of 200 consecutive robotic mitral valve repairs, with a specific focus on the
echocardiographic durability of the repaired mitral valve, confirms favorable midterm mitral
durability and improved procedural time as experience increases.2780 A simple approach to mitral valve repair: Posterior leaflet height adjustment
using a partial fold of the free edgeDCTravis O. Abicht, MD, Adin-Cristian Andrei, PhD, Jane Kruse, BSN, Eileen McDonald, RN,
Zhi Li, MS, and Patrick M. McCarthy, MD, Chicago, IllAPartial folding is a simple, reproducible technique applied as needed in patients with degenerative
MR using a precisely measured technique to reconstruct the normal A2/P2 height ratio. When
combined with a ring sized to the A2 height, SAM will be reliably avoided.2787 Systolic anterior motion of the mitral valve: A 30-year perspectivePM
Didier F. Loulmet, MD, David W. Yaffee, MD, Patricia A. Ursomanno, PhD,
Annette E. Rabinovich, BS, Robert M. Applebaum, MD, Aubrey C. Galloway, MD, and
Eugene A. Grossi, MD, New York, NYThe last 16 years of the authors’ experience with (SAM) after mitral valve repair in patients with
degenerative disease is reviewed. Posterior band annuloplasty was associated with a lower
incidence of SAM than a complete ring. The mainstay treatment of SAM continues to be medical
management.)
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S230A The Journal of Thoracic an795 Long-term follow-up of asymptomatic or mildly symptomatic patients with
severe degenerative mitral regurgitation and preserved left ventricular
function(continued on page 31A
d Cardiovascular Surgery c December 2014Gonc¸alo F. Coutinho, MD, Ana Luis Garcia, MD, Pedro M. Correia, MD, Carlos Branco, MD, and
Manuel J. Antunes, MD, PhD, Coimbra, PortugalOn evaluation of the late outcomes of asymptomatic patients with severe degenerative mitral
regurgitation and preserved left ventricular function, MV repair was achieved in the majority of
patients (98.2%) with low mortality (,1%). Patients with AF/PHT had compromised long-term
survival, particularly younger patients (aged,65 years), and were at increased risk of reoperation.2802 Natural history of coexistent tricuspid regurgitation in patients with
degenerative mitral valve disease: Implications for future guidelines
Andrew B. Goldstone, MD, Jessica L. Howard, BS, Jeffrey E. Cohen, MD,
John W. MacArthur, Jr, MD, Pavan Atluri, MD, James N. Kirkpatrick, MD, and Y. Joseph Woo, MD,
Philadelphia, Pa, and Stanford, CalifBy examining patients who underwent isolated mitral valve surgery for degenerative mitral valve
disease, we demonstrate that nonsevere coexistent functional tricuspid regurgitation is likely to
progress after surgery if uncorrected. Given the low risk of tricuspid annuloplasty, a more
aggressive strategy of concomitant tricuspid repair may be warranted.Editorial Commentary 2810 The role of cognitive dissonance in the management of functional tricuspid
regurgitation at the time of degenerative mitral valve repair
Rakesh M. Suri, MD, DPhil, and Yan Topilsky, MD, Rochester, Minn, and Tel Aviv, Israel2813 Bayesian stopping guidelines for heart valve premarket approval studies
Gary L. Grunkemeier, PhD, YingXing Wu, MD, MS, Lian Wang, MS, and Cody Hamilton, PhD,
Portland, Ore, and Irvine, CalifThe DataMonitoring Committee for a heart valve premarket approval study must decidewhether to
stop a study based on interim reviews of the data.We provide a decision aid that the DMC can use to
predict the probability that the valve will ultimately pass the objective performance criteria tests.2818 Minithoracotomy for mitral valve repair improves inpatient and postdischarge
economic savings
Eugene A. Grossi, MD, Scott Goldman, MD, J. Alan Wolfe, MD, John Mehall, MD,
J. Michael Smith, MD, Gorav Ailawadi, MD, Arash Salemi, MD, Matt Moore, MHA,
AlisonWard, MD, and Candace Gunnarsson, EdD, presented on behalf of the EconomicWorkgroup
on Valvular Surgery, New York, NY, Wynnewood, Pa, Gainesville, Ga, Colorado Springs, Colo,
Cincinnati, Ohio, Charlottesville, Va, and Irvine, CalifA national financial database was examined by propensity methodology comparing sternotomy
versus thoracotomy for mitral repair. Thoracotomy was associated with similar mortality and less
morbidity, shorter hospital stay, and significant cost savings during the primary admission.
Markedly lower readmission rates for thoracotomy will translate into additional institutional cost
savings.)
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L2823 Survival after intervention in patients with low gradient severe aortic stenosis
and preserved left ventricular function(continued on page 32A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 6 31AEAvishay Grupper, MD, Roy Beigel, MD, Elad Maor, MD, PhD, Rafael Kuperstein, MD,
Ilan Hai, MD, Olga Perelshtein, MD, Ilan Goldenberg, MD, Micha Feinberg, MD, and
Sagit Ben Zekry, MD, Tel HaShomer and Tel Aviv, IsraelED
UThe study aim was to evaluate the effect of aortic valve intervention on survival in patients with LG
severe AS and preserved EF. After aortic valve intervention, survival was significantly greater and
was comparable in patients with a low or normal SVI.Editorial Commentary 2828 Low-gradient severe aortic stenosis also benefits from aortic valve replacement
Carlos A. Mestres, MD, PhD, FETCS, Abu Dhabi, United Arab Emirates2CH830 The relative performance characteristics of the logistic European System for
Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons
score in the Placement of Aortic Transcatheter Valves trialD
G
TSNirat Beohar, MD, FACC, FSCAI, Brian Whisenant, MD, Ajay J. Kirtane, MD, SM,
Martin B. Leon, MD, E. Murat Tuzcu, MD, Raj Makkar, MD, Lars G. Svensson, MD, PhD,
D. Craig Miller, MD, Craig R. Smith, MD, Augusto D. Pichard, MD, Howard C. Herrmann, MD,
Vinod H. Thourani, MD, Wilson Y. Szeto, MD, Scott Lim, MD, Michael Fischbein, MD,
William F. Fearon, MD, William O’Neill, MD, Ke Xu, PhD, Todd Dewey, MD, and
Michael Mack, MD, Miami Beach, Fla, Salt Lake City, Utah, New York, NY, Cleveland, Ohio,
Los Angeles, CA, Stanford, Calif, Washington, DC, Philadelphia, Pa, Atlanta, Ga, Charlottesville,
Va, Detroit, Mich, and Dallas, TexThe application of the logistic European System for Cardiac Operative Risk Evaluation and the
Society of Thoracic Surgeons scores to transcatheter aortic valve replacement is controversial. The
performance of these scores in patients with inoperable or high-risk transcatheter aortic valve
replacement from the first Placement of Aortic Transcatheter Valves trial and registry was assessed.
Both scores were poor discriminators of posttranscatheter aortic valve replacement mortality,
highlighting the need for transcatheter aortic valve replacement-specific risk models.D2838 Minimally invasive aortic valve replacement with Perceval S sutureless valve:
Early outcomes and one-year survival from two European centersA
CAntonio Miceli, MD, PhD, Giuseppe Santarpino, MD, Steffen Pfeiffer, MD, Michele Murzi, MD,
Daniyar Gilmanov, MD, Giovanni Concistre, MD, Eugenio Quaini, MD, Marco Solinas, MD,
Theodor Fischlein, MD, and Mattia Glauber, MD, Massa, Italy, Bristol, United Kingdom, and
N€urnberg, GermanyPM
The aim of the present study is to evaluate the early outcomes and 1-year survival for patients
undergoing MIAVR with the Perceval S sutureless valve from 2 European cardiac centers. The
minimally invasive approach with the sutureless valve was a safe procedure with low associated
mortality and morbidity.Editorial Commentary 2843 Minimally invasive Perceval S implantation: Does this fill a sizable niche
between sutured and transcatheter aortic valve replacement?
Michael O. Kayatta, MD, Hanna A. Jensen, MD, PhD, and Vinod H. Thourani, MD, Atlanta, Ga)
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S232A The Journal of Thoracic an845 The CarboMedics supra-annular Top Hat valve improves long-term left
ventricular mass regression(continued on page 33A
d Cardiovascular Surgery c December 2014Victor X. Mosquera, MD, PhD, Alberto Bouzas-Mosquera, MD, PhD,
Victor Bautista-Hernandez, MD, PhD, Francisco Estevez-Cid, MD,
Jose M. Herrera-Nore~na, MD, PhD, Nemesio Alvarez-Garcıa, MD, PhD, and
Jose J. Cuenca-Castillo, MD, A Coru~na, SpainThe CarboMedics Top Hat valve has been developed as an enhanced-performance supra-annular
valve to be implanted above the tissue annulus. The present study assessed potential differences in
hemodynamic performance between the supra-annular Top Hat valve and intra-annular
CarboMedics standard valve in terms of long-term LV mass reduction and transvalvular gradients.2854 Three-year hemodynamic performance, left ventricular mass regression, and
prosthetic-patient mismatch after rapid deployment aortic valve replacement
in 287 patients
Axel Haverich, MD, Thorsten C. Wahlers, MD, PhD, Michael A. Borger, MD, PhD,
Malakh Shrestha, MBBS, PhD, Alfred A. Kocher, MD, Thomas Walther, MD, PhD,
Matthias Roth, MD, Martin Misfeld, MD, Friedrich W. Mohr, MD, PhD, Joerg Kempfert, MD,
Pascal M. Dohmen, MD, PhD, Christoph Schmitz, MD, Parwis Rahmanian, MD,
Dominik Wiedemann, MD, Francis G. Duhay, MD, and G€unther Laufer, MD, Hannover, Cologne,
Leipzig, Bad Nauheim, and Munich, Germany; Vienna, Austria; and Irvine, CalifThe Edwards Intuity Valve System facilitates RDAVR and is associated with a low mean gradient
and significant LV mass regression. It could provide a larger EOA than a surgical bioprosthesis,
particularly in the smaller valve sizes, and poses less risk of PPM owing to the structural valve
design.2862 Bicuspid aortic valve repair by complete conversion from ‘‘raphe’d’’ (type 1) to
‘‘symmetric’’ (type 0) morphology
Thomas G. Gleason, MD, Pittsburgh, PaNovel symmetric conversion of a type 1 bicuspid aortic valve to type 0 morphology using
concomitant cusp enlargement and translocation, annuloplasty, and valve-sparing aortic root
replacement yielded a highly functional valve that offers the potential for long-term durability.2869 Self-expanding transcatheter aortic valve replacement using alternative access
sites in symptomatic patients with severe aortic stenosis deemed extreme risk of
surgery
Michael J. Reardon, MD, David H. Adams, MD, Joseph S. Coselli, MD, G. Michael Deeb, MD,
Neal S. Kleiman, MD, Stan Chetcuti, MD, Steven J. Yakubov, MD, David Heimansohn, MD,
James Hermiller, Jr, MD, G. Chad Hughes, MD, J. Kevin Harrison, MD, Kamal Khabbaz, MD,
Peter Tadros, MD, George L. Zorn III, MD, William Merhi, MD, John Heiser, MD,
George Petrossian, MD, Newell Robinson, MD, Brijeshwar Maini, MD, Mubashir Mumtaz, MD,
Joon Sup Lee, MD, Thomas G. Gleason, MD, Jon Resar, MD, John Conte, MD, Daniel Watson, MD,
Sharla Chenoweth, MS, and Jeffrey J. Popma, MD, for the CoreValve US Clinical Investigators,
Houston, Tex; New York and Roslyn, NY; Ann Arbor and Grand Rapids, Mich; Columbus, Ohio;
Indianapolis, Ind; Durham, NC; Boston, Mass; Kansas City, Kan; Harrisburg and Pittsburgh, Pa;
Baltimore, Md; and Minneapolis, MinnWe present the results of the nonfemoral alternative access arm in the CoreValve Extreme Risk US
Pivotal Trial. The mortality rate at 30 days and 1 year was 11.3% and 36%, respectively.)
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L2877 Transapical aortic valve implantation in patients with poor left ventricular
function and cardiogenic shock(continued on page 34A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 6 33AEAxel Unbehaun, MD, Miralem Pasic, MD, PhD, Semih Buz, MD, Stephan Dreysse, MD,
Marian Kukucka, MD, PhD, Roland Hetzer, MD, PhD, and Thorsten Drews, MD, PhD, Berlin,
GermanyED
UIn the presence of a failing left ventricle or even cardiogenic shock, treatment of severe aortic
stenosis remains a surgical challenge. Without the additional trauma of cardioplegic arrest,
transcatheter aortic valve implantation is the potentially superior treatment option. Impaired left
ventricular function is quickly restored after elimination of aortic stenosis.2883 Comparison of David V valve-sparing root replacement and bioprosthetic
valve conduit for aortic root aneurysmH
DWalter F. DeNino, MD, John Matthew Toole, MD, Christopher Rowley, MD, Martha R. Stroud, MS,
and John S. Ikonomidis, MD, PhD, Charleston, SCCWe reviewed our experience with VSRR compared with BVC root replacement in an age-matched
cohort of older patients. VSRR was an effective alternative to the BVC for aortic root aneurysm,
with similar postoperativemorbidity and hemodynamic data and significantly shorter intensive care
unit and hospital length of stay.2S888 Profound hypothermia compared with moderate hypothermia in repair of
acute type A aortic dissectionT
GKhaled D. Algarni, MD, MHSc, FRCSC, Bobby Yanagawa, MD, PhD,
Vivek Rao, MD, PhD, FRCSC, and Terrence M. Yau, MD, MSc, FRCSC, Riyadh, Saudi Arabia, and
Toronto, Ontario, CanadaTo determine the impact of the degree of hypothermia on surgical outcomes in patients undergoing
repair of acute type A aortic dissection, we compared profound hypothermia and moderate
hypothermia. Moderate hypothermia was independently associated with a lower risk of a composite
outcome of mortality and major adverse cardiac and cerebrovascular events.Editorial Commentary 2894 Hypothermic circulatory arrest is not just about temperature A
CDKevin L. Greason, MD, Rochester, Minn2896 Antegrade versus retrograde cerebral perfusion for hemiarch replacement
with deep hypothermic circulatory arrest: Does it matter?
A propensity-matched analysisMAsvin M. Ganapathi, MD, Jennifer M. Hanna, MD, MBA, Matthew A. Schechter, MD,
Brian R. Englum, MD, Anthony W. Castleberry, MD, MMCi, Jeffrey G. Gaca, MD, and
G. Chad Hughes, MD, Durham, NC
P
The choice of cerebral perfusion strategy for aortic arch surgery has been debated, and the
superiority of ACP or RCP has not been shown. We demonstrate that in both elective and
nonelective hemiarch surgery, equivalent neurologic outcomes can be achieved with either ACP or
RCP.Editorial Commentary 2S902 Brain protection in aortic arch surgery: Antegrade cerebral perfusion and
retrograde cerebral perfusion need a tougher row to hoe/BJohn A. Elefteriades, MD, and Bulat A. Ziganshin, MD, New Haven, Conn, and Kazan, Russia)
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S234A The Journal of Thoracic an905 Embolic capture with updated intra-aortic filter during coronary artery
bypass grafting and transaortic transcatheter aortic valve implantation:
First-in-human experience(continued on page 35A
d Cardiovascular Surgery c December 2014Jian Ye, MD, and John G. Webb, MD, Vancouver, British Columbia, CanadaWe used the new version of the EMBOL-X intra-aortic filter in 2 transaortic transcatheter aortic
valve implantation and 3 coronary artery bypass grafting procedures. There were no complications
related to the use of filters. Microemboli were retrieved from all 5 patients.2911 Is there a need for adjunct cerebral protection in conjunction with deep
hypothermic circulatory arrest during noncomplex hemiarch surgery?
Tsuyoshi Kaneko, MD, Sary F. Aranki, MD, Robert C. Neely, MD, Farhang Yazdchi, MD,
Siobhan McGurk, BSc, Marzia Leacche, MD, and Prem S. Shekar, MD, Boston, MassDifferent cerebral protection strategies are currently being practiced during noncomplex hemiarch
surgery without randomized control studies to demonstrate their relative efficacy. We compared
outcomes for various cerebral protection strategies in noncomplex hemiarch surgery in 467
patients. Operative mortality, morbidity, and long-term outcomes were similar between deep
hypothermic circulatory arrest alone, deep hypothermic circulatory arrest with antegrade cerebral
perfusion, and deep hypothermic circulatory arrest with retrograde cerebral perfusion. Deep
hypothermic circulatory arrest alone is as safe as other adjunct complex cerebral protection
techniques in this patient subset.Editorial Commentary 2917 Belt and suspenders: Can we keep them in the drawer?
Joseph Schmoker, MD, Burlington, Vt2920 Direct innominate artery cannulation for selective antegrade cerebral
perfusion during deep hypothermic circulatory arrest in aortic surgery
Vinay Garg, BHSc, Dimitrios N. Tsirigotis, MD, PhD, Jeff Dickson, MD,
Constantine Dalamagas, CPC, David A. Latter, MD, Subodh Verma, MD, PhD, and
Mark D. Peterson, MD, PhD, Toronto, Ontario, CanadaWe have demonstrated that direct cannulation of the innominate artery using a 14F pediatric venous
cannula is a simple, reproducible, safe, and effective technique for establishing antegrade cerebral
perfusion in patients undergoing aortic surgery and requiring open distal anastomosis or hemiarch
replacement.Editorial Commentary 2924 Innominate artery cannulation: The Toronto technique for antegrade cerebral
perfusion in aortic arch reconstruction—a clinical trial opportunity for the
International Aortic Arch Surgery Study Group
John G. Augoustides, MD, FASE, FAHA, Nimesh D. Desai, MD, Wilson Y. Szeto, MD, and
Joseph E. Bavaria, MD, Philadelphia, Pa2927 Safety and efficacy of retrograde cerebral perfusion as an adjunct for cerebral
protection during surgery on the aortic arch
Leonard N. Girardi, MD, Nikolay Shavladze, MD, Art Sedrakyan, PhD, and
Siyamek Neragi-Miandoab, MD, New York, NYRCP as an adjunct to PHCA is a safe and reliable method for neurologic protection during aortic
arch reconstruction. In those patients requiring longer periods of PHCA, the incidence of PND,
TND, and perioperative mortality was low and similar to those undergoing less complex arch
reconstruction.)
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surgery: Evidence from a comprehensive meta-analysis of comparative studies
on 4476 patients(continued on page 36A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 6 35AE
ED
UUmberto Benedetto, MD, PhD, Shahzad G. Raja, MRCS, FRCS(C-Th),
Mohamed Amrani, MD, PhD, John R. Pepper, MD, FRCS, Mohamed Zeinah, FRCS(C-Th),
Euclide Tonelli, MD, Giuseppe Biondi-Zoccai, MD, and Giacomo Frati, MD, London,
United Kingdom; Cairo, Egypt; and Latina and Pozzilli, ItalyThere is a growing perception that peripheral cannulation through the femoral artery, by reversing
the flow in the thoracoabdominal aorta, may increase the risk of retrograde brain embolization. The
present meta-analysis supports the superiority of central cannulation approaches that allow
antegrade flow in proximal aortic and arch surgery.2H944 Open aortic arch reconstruction after previous cardiac surgery: Outcomes of
168 consecutive operationsD
CEduard Quintana, MD, FETCS, Pietro Bajona, MD, Hartzell V. Schaff, MD,
Joseph A. Dearani, MD, Richard C. Daly, MD, Kevin L. Greason, MD, and Alberto Pochettino,MD,
Rochester, Minn, and Barcelona, SpainSAortic arch reconstruction after previous sternotomy for cardiovascular surgery has acceptable
morbidity and mortality (permanent stroke, 5.4%; operative mortality, 8.3%). The extent of arch
reconstruction was not a risk factor for early mortality. Patients with previous coronary artery
bypass grafts and patients with endocarditis had poorer long-term survival.T2951 Results of type II hybrid arch repair with zone 0 stent graft deployment for
complex aortic arch pathologyGWilliam D. T. Kent, MD, MSc, Jehangir J. Appoo, MDCM, Joseph E. Bavaria, MD,
Eric J. Herget, MD, Patrick Moeller, MS, Alberto Pochettino, MD, and Jason K. Wong, MD,
Calgary, Alberta, Canada, Philadelphia, Pa, and Rochester, MinnA
CDThe type II hybrid arch procedure involves replacement of the ascending aorta, arch debranching,
and antegrade stent graft deployment. This single-stage operation without circulatory arrest can be
performed for acute and chronic diffuse aortic arch pathology. Early experience suggests
acceptable clinical outcomes at mean follow-up of 18.5 months.2956 Endovascular repair for blunt thoracic aortic injury: 11-year outcomes and
postoperative surveillance experience
Konstantinos Spiliotopoulos, MD, John Kokotsakis, MD, Michalis Argiriou, MD,
Panagiotis Dedeilias, MD, Dimosthenis Farsaris, MD, Theodore Diamantis, MD, and
Christos Charitos, MD, Stanford, Calif, and Athens, GreecePMMidterm postoperative surveillance for patients after blunt thoracic aortic injury undergoing stable
thoracic endovascular aortic repair could be less intense and equally safe, resulting in significant
reductions in imaging risks and costs.Editorial Commentary 2962 Endovascular repair for blunt thoracic aortic injury: A safe and durable
procedure
Cipriano Abad, MD, Las Palmas de Gran Canaria, Spain)
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S236A The Journal of Thoracic an963 Renal and visceral protection in thoracoabdominal aortic surgery(continued on page 37A
d Cardiovascular Surgery c December 2014Muhammad Aftab, MD, and Joseph S. Coselli, MD, Houston, TexOpen thoracoabdominal aortic aneurysm repair carries a substantial risk of perioperative morbidity
and mortality, primarily from distal aortic ischemia. Advances in surgical techniques, adjuncts, and
strategies focusing on renal and visceral protection have greatly improved surgical outcomes by
substantially reducing renal and visceral ischemic complications.2967 Reoperations on the total aortic arch in 119 patients: Short- and mid-term
outcomes, focusing on composite adverse outcomes and survival analysis
Ourania Preventza, MD, Andrea Garcia, MD, Denton A. Cooley, MD, Alexandra Tuluca, MD,
Katherine H. Simpson, MS, Faisal G. Bakaeen, MD, Shuab Omer, MD, Lorraine Cornwell, MD,
Todd K. Rosengart, MD, and Joseph S. Coselli, MD, Houston, TexAortic arch surgery can be challenging, especially in patients with previous proximal aortic surgery.
We have determined the preoperative and perioperative risk factors in patients undergoing
reoperative aortic arch surgery and performed a survival analysis of this group.2973 Ascending aortic dilatation is rarely associated with coronary artery disease
regardless of aortic valve morphology
Veronica Jackson, MD, PhD, Maria J. Eriksson, MD, PhD, Kenneth Caidahl, MD, PhD,
Per Eriksson, PhD, and Anders Franco-Cereceda, MD, PhD, Stockholm, SwedenClinical characteristics were evaluated in 702 patients with aortic valve and/or ascending aortic
pathology; 202 had concomitant coronary artery disease. Coronary artery disease and aortic
dilatation rarely coexist. Differences in prevalence of coronary artery disease or aortic dilatation
between patients with bicuspid and tricuspid aortic valves are not explained by differences in
clinical characteristics.2981 Long-term results of aggressive hemiarch replacement in 534 patients with
type A aortic dissection
Bartosz Rylski, MD, Rita K. Milewski, MD, PhD, Joseph E. Bavaria, MD,
Prashanth Vallabhajosyula, MD, William Moser, CRNP, Wilson Y. Szeto, MD, and
Nimesh D. Desai, MD, PhD, Philadelphia, Pa, and Freiburg, GermanyIn patients with acute type A aortic dissection hemiarch replacement can be performed with low
mortality and low aortic arch reoperation rate. Marfan syndrome and DeBakey type I dissection are
independent predictors of distal aortic reintervention.2986 Outcomes of open distal aortic aneurysm repair in patients with chronic
DeBakey type I dissection
Joseph S. Coselli, MD, Susan Y. Green, MPH, Samantha Zarda, MS, Courtney C. Nalty, MSPH,
Matt D. Price, MS, Michael S. Hughes, BM, Ourania Preventza, MD, Kim I. de la Cruz, MD, and
Scott A. LeMaire, MD, Houston, TexWe analyzed data regarding 198 open descending thoracic or thoracoabdominal aortic repairs in
patients with chronic DeBakey type I aortic dissection. Therewere 14 early deaths (7%). Permanent
paraplegia developed in 2 patients (1%), 5 patients (3%) had stroke, and 9 patients (5%) had renal
failure. Actuarial 8-year survival was 65.6% 6 5.9%.)
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Dissection in China(continued on page 38A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 6 37AEWeiguang Wang, MD, Weixun Duan, MD, Yang Xue, MD, Ling Wang, PhD, Jincheng Liu, MD,
Shiqiang Yu, MD, and Dinghua Yi, MD, on behalf of the Registry of Aortic Dissection in China
(Sino-RAD) Investigators, Xi’an, Shaanxi, People’s Republic of ChinaED
UThe first Sino-RAD, including 15 large cardiovascular centers throughout China, was established.
Our data were compared with those reported by IRAD. We found that, compared with Western
populations, Chinese patients with AAD had an earlier onset, a low incidence of hypertension, a
high incidence of back pain, great differences in the choice of therapeutic strategies, and relatively
low in-hospital mortality and more were men.Editorial Commentary 3001 Examining the face of aortic dissection outside the Western worldDJohn A. Elefteriades, MD, and Bulat A. Ziganshin, MD, New Haven, Conn, and Kazan, Russia3003 Uncovered stent implantation in complicated acute aortic dissection type B C
HAlexander Massmann, MD, Takashi Kunihara, PhD, MD, Peter Fries, MD,
G€unther Schneider, PhD, MD, Arno Buecker, MD, and Hans-Joachim Sch€afers, MD, Homburg,
Germany, and Tokyo, JapanG
TSComplicated AADB with suspicion of visceral ischemia or claudication should prompt for
immediate intervention. Thoracoabdominal uncovered stent implantation proved to be a safe and
effective favorable treatment approach. Relief of acute ischemia in complicated AADB was
achieved without delay, and the fatal scenario of intestinal gangrene was successfully prevented.Editorial Commentary 3012 To stent or stent-graft? It depends
James I. Fann, MD, Stanford, Calif3014 Preoperative transcatheter occlusion of bronchopulmonary collateral artery
reduces reperfusion pulmonary edema and improves early hemodynamic
function after pulmonary thromboendarterectomyD
A
CHui-Li Gan, MD, Jian-Qun Zhang, MD, Jian-Chao Sun, MD, Lei Feng, MD,
Xiao-Yong Huang, MD, Jia-Kai Lu, MD, and Xiu-Hua Dong, MD, Beijing, ChinaThe use of PTOBPCA reduced the incidence of RPE after PEA in patients diagnosed with CTEPH.3020 Predictors of outcome and different management of aortobronchial and
aortoesophageal fistulasMVictor X. Mosquera, MD, PhD, Milagros Marini, MD, PhD, Francisco Pombo-Felipe, MD, PhD,
Pablo Gomez-Martinez, MD, Carlos Velasco, MD, Jose M. Herrera-Nore~na, MD, PhD, and
Jose J. Cuenca-Castillo, MD, A Coru~na, Spain
PAEFs and ABFs are uncommon, but life-threatening, conditions whose outcomes are ultimately
determined by the etiology of the fistulas. Both open and endovascular management of aortic
fistulas can prevent death by exsanguination; however, patients remain at high risk of infectious
complications. Failure to treat the underlying cause will result in poor midterm outcomes.)
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S338A The Journal of Thoracic an027 Association of operative risk with the outcome of concomitant Cox Maze
procedure: A comparison of results across risk groups(continued on page 39A
d Cardiovascular Surgery c December 2014Niv Ad, MD, Sari D. Holmes, PhD, Graciela Pritchard, BS, and Deborah J. Shuman, BS,
Falls Church, VaPatients undergoing cardiac surgery with atrial fibrillation face increased risks for morbidity and
mortality, yet only 39% undergo surgical ablation. This study indicates that the Cox maze III/IV
procedure can be performed safely in patients with higher operative risk and should be considered
carefully in patients with a history of atrial fibrillation.Editorial Commentary 3034 Why do most patients with atrial fibrillation referred for other cardiac surgery
not receive concomitant ablation? A plea for a more aggressive surgical
approach
Ralph J. Damiano, Jr, MD, St Louis, Mo3036 Society of Thoracic Surgeons 2008 cardiac risk models predict in-hospital
mortality of heart valve surgery in a Chinese population: A multicenter study
Lv Wang, MD, Fang-Lin Lu, MD, PhD, Chong Wang, MD, PhD, Meng-Wei Tan, MD, PhD, and
Zhi-yun Xu, MD, PhD, Shanghai and Baoding, ChinaSociety of Thoracic Surgeons 2008 cardiac surgery risk models were validated at 4 cardiac centers
in China for patients undergoing valve surgery. The Society of Thoracic Surgeons 2008 risk models
showed better performance in patients undergoing single valve surgery than in patients undergoing
multiple valve surgery.3042 Early experience treating tricuspid valve endocarditis with a novel
extracellular matrix cylinder reconstruction
Marc W. Gerdisch, MD, W. Douglas Boyd, MD, John L. Harlan, MD, John B. Richardson, Jr, MD,
Joseph E. Flack III, MD, Brian A. Palafox, MD, William E. Johnson III, MD, Benjamin Sun, MD,
Richard Lee, MD, T. Sloane Guy, MD, Gyu I. Gang, MD, James L. Cox, MD, and
Vivek Rao, MD, PhD, Indianapolis, Ind; Sacramento and Orange, Calif; Birmingham and Mobile,
Ala; Minneapolis, Minn; Springfield, Mass; St Louis, Mo; Philadelphia, Pa; Mesa, Ariz; and
Toronto, Ontario, CanadaA tubular bioprosthetic valve constructed of an ECM-based biomaterial was successfully used to
treat isolated tricuspid infective endocarditis in 18 patients.3049 Performance of the European System for Cardiac Operative Risk
Evaluation II: A meta-analysis of 22 studies involving 145,592 cardiac surgery
procedures
Pietro Guida, PhD, Florinda Mastro, MD, Giuseppe Scrascia, MD, PhD,
Richard Whitlock, MD, PhD, FRCSC, and Domenico Paparella, MD, Bari, Italy, and Hamilton,
CanadaThe euroSCORE II provides an accurate prediction of operative mortality after cardiac surgery. As
a generic risk model for contemporary practice, the score shows good discrimination and overall
calibration of the predictions when the results from different validation studies are meta-analyzed.)
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Hospital, Cape Town, South Africa: Causes and perioperative outcomes in the
HIV era (1990-2012)(continued on page 40A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 6 39AE
D
UArthur K. Mutyaba, MBChB, Sarvesh Balkaran, Robert Cloete, Naude du Plessis,
Motasim Badri, PhD, Johan Brink, FCS(SA), and Bongani M. Mayosi, DPhil, FCP(SA),
Cape Town, South Africa, and Riyadh, Kingdom of Saudi ArabiaENot much is known about pericardiectomy for constrictive pericarditis in the developing world. The
present study is the largest on the subject emanating from Africa in the HIV/AIDS era. Our results
highlight the importance of early referral for pericardiectomy for patients with constrictive
pericarditis and the safety of surgery for those infected with HIV/AIDS.3066 Outcomes of patients with human immunodeficiency virus infection
undergoing cardiovascular surgery in the United StatesH
DCMichael P. Robich, MD, Nicholas Schiltz, PhD, Douglas R. Johnston, MD, Stephanie Mick, MD,
Wayne Tse, BS, Colleen Koch, MD, MS, MBA, and Edward G. Soltesz, MD, MPH, Cleveland, OhioAn increasing number of HIV+ patients are undergoing cardiovascular operations. This study uses a
large administrative database to show that HIV does not affect mortality, length of stay, or cost, but
does predispose patients to an increased number of blood transfusions. Rates of wound infection,
pneumonia, and renal failure are similar between HIV+ and HIV2 patients, whereas stroke is less
common in the HIV+ group. Cardiovascular surgery can be performed safely on HIV+ patients.SPerioperative
Management (PM)
3076 Acute Risk Change for Cardiothoracic Admissions to Intensive Care
(ARCTIC index): A new measure of quality in cardiac surgeryG
TTim G. Coulson, BM, BSc, Michael Bailey, PhD, MSc, Christopher M. Reid, PhD,
Lavinia Tran, PhD, BBiomedsci, Daniel V. Mullany, MBBS, MMedSc, FCICM, FANZCA,
Julian A. Smith, MS, FRACS, and David Pilcher, MBBS, MRCP, FRACP, FCICM, Melbourne and
Brisbane, AustraliaD
A
CThe Acute Risk Change for Cardiothoracic Admissions to Intensive Care index is a new measure of
overall quality in cardiac surgery derived from the difference in mortality risk between pre- and
postoperative phases. The index was associated with knownmarkers of perioperative performance and
postoperative morbidity. In the future the index may help discriminate between cardiac surgical units.Editorial Commentary 3082 Quality assessment in cardiac surgery:Measuring accurately, fairly, and easily,
focusing on what can be changed
Oz M. Shapira, MD, Jerusalem, Israel3
PM084 Geographic variability in potentially discretionary red blood cell transfusions
after coronary artery bypass graft surgery
Donald S. Likosky, PhD, Paul M. Al-Attar, BS, David J. Malenka, MD, Anthony P. Furnary, MD,
Eric J. Lehr, MD, PhD, Gaetano Paone, MD, MHSA, Mallika Kommareddi, MPH,
Robert Helm, MD, Ruyun Jin, MD, MCR, Charles Maynard, PhD, Eric C. Hanson, MD,
ElaineM. Olmstead, BA, Todd A. Mackenzie, PhD, Cathy S. Ross, MS, andMin Zhang, PhD, for the
Cardiac Surgery Quality Improvement Network, Ann Arbor, Detroit, and Troy, Mich; Hanover and
Portsmouth, NH; Portland, Ore; and Seattle, WashB
SET
/We assessed regional differences in potentially discretionary transfusions (,3 units red blood cells)
across 56 medical centers and 11,200 patients undergoing isolated nonemergent coronary artery
bypass graft surgery. Regional variation in overall red blood cell transfusion rates remained after
risk adjustment, perhaps due to differences in regional practice environments.)
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d Cardiovascular Surgery c December 2014Victor A. Ferraris, MD, PhD, Lexington, Ky3092 Should clopidogrel be discontinued before coronary artery bypass grafting for
patients with acute coronary syndrome?A systematic review andmeta-analysis
Christopher Cao, MBBS, Praveen Indraratna, MBBS, Su C. Ang, MBBS, Con Manganas, MBBS,
John Park, MBBS, Paul G. Bannon, MBBS, PhD, and Tristan D. Yan, MBBS, MD, PhD, Sydney,
AustraliaThe results of the present meta-analysis suggest that patients who present with ACS should be
treated with dual antiplatelet therapy, including clopidogrel. However, for patients subsequently
referred for CABG, a minimum washout period of 5 days should be observed to minimize
perioperative bleeding and bleeding-related complications, unless emergency indications exist.Editorial Commentary 3099 Right here waiting...?
Song Wan, MD, FRCS, Hong Kong, China3101 Extubating in the operating room after adult cardiac surgery safely improves
outcomes and lowers costs
Vinay Badhwar, MD, Stephen Esper, MD, Maria Brooks, PhD, Suresh Mulukutla, MD,
Regina Hardison, MS, Demetri Mallios, BS, Danny Chu, MD, Lawrence Wei, MD, and
Kathirvel Subramaniam, MD, Pittsburgh, PaAfter nonemergent open cardiac surgery, including redo and multivalve procedures, protocolized
OR extubation was propensity matched to early postoperative fast-track ICU extubation. OR
extubation was safely associated with significant reductions in the ICU stay and total length of stay,
discharge skilled nursing requirements, and postoperative cost.3110 The impact of frailty on outcomes after cardiac surgery: A systematic review
Aresh Sepehri, BSc, Thomas Beggs, Ansar Hassan, MD, PhD, FRCSC,
Claudio Rigatto, MD, MSc, FRCPC, Christine Shaw-Daigle, BA, MLS, AHIP,
Navdeep Tangri, MD, PhD, FRCPC, and Rakesh C. Arora, MD, PhD, FRCSC, FACS, Vancouver,
British Columbia, Winnipeg, Manitoba, and Halifax, Nova Scotia, Canada; and Dublin, IrelandFrailty assessments are used to assess physiologic functioning capacity in the geriatric population.
Frailty has been linked to cardiovascular disease. Our review found frailty to be predictive of
cardiac postoperative outcomes. Further study is needed to determine which frailty assessment, or
component of frailty, is most predictive.Editorial Commentary 3117 Frailty: It’s hard to define, but you know it when you see it
Keith B. Allen, MD, Kansas City, Mo3119 Assessment of platelet function with light transmission aggregometry in
24 patients supported with a continuous-flow left ventricular assist device:
A single-center experience
Mathieu Fiore, MD, Chloe James, MD, PhD, Christine Mouton, MD, Joachim Calderon, MD,
Laurent Barandon, MD, PhD, Alexandre Ouattara, MD, PhD, and Franc¸ois Picard, MD,
Pessac and Bordeaux, FranceWe successfully used light transmission aggregometry to test platelet function in 24 patients with a
HeartMate II continuous-flow left ventricular assist device. High platelet reactivity during
treatment with aspirin was common in these patients, even after an extended period. Aspirin
regimens were therefore progressively adjusted until antiplatelet therapy was effective.)
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The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 6 41AESimon Body, MBChB, MPH, FAHA, and Gregory Couper, MD, Boston, Mass3127 Volatile anesthetics in preventing acute kidney injury after cardiac surgery:
A systematic review and meta-analysisU
EDJieru Cai, MD, Rende Xu, MD, PhD, Xiaofang Yu, MD, PhD, Yi Fang, MD, PhD, and
Xiaoqiang Ding, MD, PhD, Shanghai, ChinaIn this meta-analysis, we evaluated the protective role of volatile anesthetics on renal function in
patients undergoing cardiac surgery. We found that volatile anesthetics significantly reduced the
incidence of acute kidney injury. Moreover, patients receiving volatile anesthetics had significantly
reduced incidence of prolonged intensive care unit stay and hospitalization.Editorial Commentary 3H137 Volatile anesthetics in cardiac surgery: Renoprotective, cardioprotective,
neither, or both?D
CNicholas D. Andersen, MD, Durham, NC3139 The influence of positive end-expiratory pressure on stroke volume variation in
patients undergoing cardiac surgery: An observational study
Woon-Seok Kang, MD, Seong-Hyop Kim, MD, PhD, Sung Yun Kim, MD, Chung-Sik Oh, MD,
Song-Am Lee, MD, and Jun-Seok Kim, MD, PhD, Seoul, KoreaS
G
TThe absolute values of stroke volume variation may be affected by different levels of positive
end-expiratory pressure in mechanically ventilated patients. Accurate volume status and fluid
responsiveness in patients must be considered.Editorial Commentary 3146 To give or not to give? Are we ready to use noninvasive monitors to guide fluid
management in cardiothoracic surgical patients?
Rakesh C. Arora, MD, PhD, FRCSC, Winnipeg, Manitoba, Canada3D148 Ventilator-associated pneumonia after cardiac surgery: A meta-analysis and
systematic reviewA
CSiyi He, MD, Bocheng Chen, MD, Wei Li, MD, Junyan Yan, MD, Lin Chen, MD,
Xuefeng Wang, MD, and Yingbin Xiao, MD, Chongqing and Chengdu, ChinaThis meta-analysis focuses on ventilator-associated pneumonia after cardiac surgery, to provide a
systematic and comprehensive description of its prevalence, etiology, risk factors, and clinical
outcomes.Editorial Commentary 3
M155 Prevention of ventilator-associated pneumonia in the cardiothoracic intensive
care unit: Back to basics
PNicholas D. Andersen, MD, Durham, NC)
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S342A The Journal of Thoracic an157 Clostridium difficile infection after cardiac surgery: Prevalence, morbidity,
mortality, and resource utilization(continued on page 43A
d Cardiovascular Surgery c December 2014Suresh Keshavamurthy, MBBS, MS, Colleen G. Koch, MD, MS, MBA, Thomas G. Fraser, MD,
Steven M. Gordon, MD, Penny L. Houghtaling, MS, Edward G. Soltesz, MD, MPH,
Eugene H. Blackstone, MD, and G€osta B. Pettersson, MD, PhD, Cleveland, OhioCDI contributes to morbidity and mortality after cardiac surgery. Although rare, its prevalence has
increased over the last 2 decades. Prolonged hospitalization, antibiotics, comorbidities, and high-
risk operations are common among patients with CDI. If toxic colitis develops, mortality is very
high, but colectomy may be lifesaving.Evolving Technology/
Basic Science (ET/BS)
3166 Right ventricular architecture responsible for mechanical performance:
Unifying role of ventricular septum
Gerald Buckberg, MD, and Julien I. E. Hoffman, MD, Los Angeles and San Francisco, CalifThe right ventricle contains a freewall (transverse fibers [bellows effect]) and septum (helical fibers
[80% RV function]) occupying 40% of the ventricular mass. This relationship underscores the
decisions regarding RVor biventricular failure, pulmonary insufficiency, RV dysplasia, LVAD,
transplantation, congenital defects, and myocardial protection.3172 Differential effects of atorvastatin on autophagy in ischemic and nonischemic
myocardium in Ossabaw swine with metabolic syndrome
Ashraf A. Sabe, MD, Nassrene Y. Elmadhun, MD, Ahmed A. Sadek, BS, Louis M. Chu, MD,
Cesario Bianchi, MD, PhD, and Frank W. Sellke, MD, Providence, RIAutophagy is a homeostatic mechanism that has been shown to be cardioprotective. In a clinically
relevant swine model of metabolic syndrome, we found atorvastatin to differentially regulate
autophagy signaling, stimulating autophagy in nonischemic myocardium while partly inhibiting it
in chronically ischemic myocardium.Editorial Commentary 3178 Cardiac cannibalism
Alden H. Harken, MD, FACS, Oakland, Calif3180 Targeting survival pathways to create infarct-spanning bridges of human
embryonic stem cell–derived cardiomyocytes
Jun Luo, MD, PhD, Matthew S. Weaver, PhD, James E. Dennis, PhD, Elizabeth Whalen, PhD,
Michael A. Laflamme, MD, PhD, and Margaret D. Allen, MD, Seattle, WashPreimplant treatment of human embryonic stem cell–derived cardiomyocytes with cytoprotective
cobalt protoporphyrin promoted graft survival within acute myocardial infarcts, providing a means
to regenerate infarct-spanning bands of ventricular myocytes. A concomitant course of
systemically delivered cobalt protoporphyrin increased graft size and infarct wall thickness while
reducing adverse ventricular remodeling.Editorial Commentary 3188 Cardiac stem cell therapy: Checkered past, promising future?
John J. Squiers, BSE, Kelley A. Hutcheson, MD, Jeffrey E. Thatcher, PhD, and
J. Michael DiMaio, MD, Dallas and Plano, Tex)
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resistance to calcification in mitral and pulmonary implantations in a juvenile
sheep model(continued on page 44A
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UChristian P. Brizard, MD, MS, Johann Brink, MBBS, Steven B. Horton, PhD,
Glenn Anthony Edwards, BVSc, MANZCSc, John C. Galati, PhD, BSc, and
William M. L. Neethling, PhD, FACA, Melbourne, Parkville, and Perth, AustraliaEWe conducted a test of noninferiority for CardioCel (Admedus, Brisbane, Australia), a bovine
pericardium chemically engineered and cross-linked with low concentration monomeric
glutaraldehyde, against autologous pericardium treated intraoperatively with glutaraldehyde in a
chronic juvenile sheep model of pulmonary and mitral valve reconstruction. The results were
favorable to CardioCel, which demonstrated controlled limited healing process and no
calcification.Editorial Commentary 3 C202 The quest for a durable bioengineered tissue for the treatment of valvular heart
diseaseH
DNiv Ad, MD, Falls Church, Va3204 Feasibility of near-infrared spectroscopic tomography for intraoperative
functional cerebral monitoring: A primate studyG
TSDaniel C. Lee, MD, Tigran Gevorgyan, MD, Harry L. Graber, PhD, Douglas S. Pfeil, PhD,
Yong Xu, PhD, Sundeep Mangla, MD, Frank C. Barone, PhD, Jenny Libien, MD, PhD,
Jean Charchaflieh, MD, MPH, DrPH, John G. Kral, MD, PhD, Sergio A. Ramirez, MD,
LeRone Simpson, MD, and Randall L. Barbour, PhD, Oklahoma City, Okla; Brooklyn and
New Rochelle, NY; Los Angeles, Calif; New Haven, Conn; and Lubbock, TexNIRS tomography accurately captured cerebral ischemia, vasodilatation, and hemorrhage in an
experimental primate model in real time. Thus, usage for functional cerebral monitoring in the
operating room could be feasible.Editorial Commentary 3211 Neuromonitoring during cardiothoracic surgery: The signal and the noiseDAbe DeAnda, Jr, MD, New York, NY C3213 Rapidly switching multidirectional defibrillation: Reversal of ventricular
fibrillation with lower energy shocksAMarcelo A. Viana, MEE, Rosana A. Bassani, ScD, Orlando Petrucci, MD, PhD,
Denilson A. Marques, BEE, and Jose Wilson M. Bassani, PhD, Campinas, BrazilPMDefibrillators are used to restore sinus rhythm during arrhythmia and cardiac arrest. This study
shows that in vivo defibrillation by direct cardiac stimulation with shocks applied in 3 directions
requires lower shock energy than unidirectional stimulation. This indicates that multidirectional
stimulation is safer for cardiac defibrillation.3219 Pilot study of pulmonary arterial branch sealing using energy devices in an
ex vivo model
Moishe Liberman, MD, PhD, Mohamed Khereba, MB, BCh, Eric Goudie, MD,
Jordan Kazakov, MD, Vicky Thiffault, RN, Edwin Lafontaine, MD, and Pasquale Ferraro, MD,
Montreal, Quebec, Canada/B
SETThis study evaluates and compares the immediate efficacy of 4 modern energy sealing devices used
to seal pulmonary artery branches in a simulated ex vivo pulmonary artery branch sealing model.
Pulmonary artery vascular sealing using energy was effective and was able to sustain high
intraluminal bursting pressures.)
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d Cardiovascular Surgery c December 2014Xiaosai Yao, PhD, Christina Williamson, MD, Viktor A. Adalsteinsson, BS,
Richard S. D’Agostino, MD, Torin Fitton, MD, Gregory G. Smaroff, MD, Robert T. William, BS,
K. Dane Wittrup, PhD, and J. Christopher Love, PhD, Cambridge and Burlington, MassThe malignancy of epithelial cells mobilized into the pulmonary vein during lobectomy was
determined using single-cell genetic approaches. We found that tumor cells along with many
normal epithelial cells were shed intraoperatively. Cytomorphological examination alone cannot
always distinguish between normal and tumor cells.Cardiothoracic Imaging 3232 An extreme case of aortic root pseudoaneurysm after allograft root
replacement: A technical challenge
Syed T. Hussain, MD, Eugene H. Blackstone, MD, and G€osta B. Pettersson, MD, PhD,
Cleveland, Ohio3234 Iatrogenic innominate arteriovenous fistula repaired with the stent-graft
Bo Fu, MD, Li Dong, MD, and Jian Yang, MD, Chengdu, China3236 Vascular ring connector–related pseudoaneurysm of the descending aorta
Jer-Shen Chen, MD, Chun-Yang Huang, MD, and Jih-Hsin Huang, MD, New Taipei City, Taiwan3238 Multimodal imaging of a rare type of giant aortic arch aneurysm with
malformation of the aortic arch
Da Zhu, MD, and Zhong Wu, MD, Sichuan, China3240 Mobile right ventricular myxoma traversing chambers during cardiac cycle
Adam Khan, BA, Nicholas R. Teman, MD, and Bo Yang, MD, PhD, Ann Arbor, Mich3242 Giant aneurysm of a major aortopulmonary collateral artery in a 56-year-old
woman
Jae Gun Kwak, MD, Chang-Ha Lee, MD, and Seong Ho Kim, MD, Bucheon, Gyonggi,
Republic of Korea3244 Tracheal diverticulum: An atypical presentation
Anshul Srivastava, BS, Julian Guitron, MD, and Valerie A. Williams, MD, Cincinnati, OhioSurgical Techniques 3246 New technique for passage of endograft through problematic arch anatomy
Hitoshi Matsuda, MD, Tetsuya Fukuda, MD, Hiroshi Tanaka, MD, and Kenji Minatoya, MD,
Osaka, Japan3247 Minimally invasive robotically assisted surgical resection of left atrial
endocardial papillary fibroelastomas
Alina Hua, MBBS, Richard J. Shemin, MD, Jeffrey P. Gordon, MD, and Eric H. Yang, MD, London,
United Kingdom, and Los Angeles, Calif3250 Subxiphoid single-incision thoracoscopic left upper lobectomy
Chia-Chuan Liu, MD, Bing-Yen Wang, MD, Chih-Shiun Shih, MD, and Yun-Hen Liu, MD, Taipei,
Taichung, and Keelung, Taiwan)
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e241 Neonatal double switch for congenitally corrected transposition with Ebstein
anomaly and bilateral superior venae cavae(continued on page 46A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 6 45AEVinod A. Sebastian, MD, Andrea Cooley, DO, Claudio Ramaciotti, MD, Kristine J. Guleserian, MD,
and Joseph M. Forbess, MD, Dallas, TexeE243 Biventricular assist device implantation as bridge to transplantation after
Mustard procedureD
UAbdul Rahman Dakkak, MD, Angelo M. Dell’Aquila, MD, Juergen R. Sindermann, PhD, and
Andreas Rukosujew, PhD, Muenster, GermanyLetters to the Editor 3252 Re: Interpapillary muscle distance independently affects severity of functional
mitral regurgitation in patients with systolic left ventricular dysfunction
Robert W. M. Frater, MBChB, MSSurg, FRCS, Bronx, NYD3252 Why does papillary separation play a major role in functional mitral
regurgitation caused by left ventricular function?CHShuichiro Kaji, MD, Kitae Kim, MD, and Yutaka Furukawa, MD, Kobe, Japan3254 Management of mild aortic valve stenosis in rheumatic mitral surgery
Zhi-Wei Zhang, MD, Tian-Xiang Gu, MD, PhD, and Zong-Yi Xiu, MD, Shenyang, China3T255 Routine aortic valve replacement for mild stenosis is not necessary during
rheumatic mitral surgeryS
GHo Young Hwang, MD, PhD, and Hyuk Ahn, MD, PhD, Seoul, Korea3255 Antiplatelet therapy as sole anticoagulant in patients with aortic mechanical
prostheses
Raul Garcıa-Rinaldi, MD, PhD, Mayaguez, Puerto Rico3D256 Re: Predictors of outcome and different management of aortobronchial and
aortoesophageal fistulasCAntonio Bozzani, MD, and Franco Ragni, MD, Pavia, ItalyA3257 The key for successfully managing aortobronchial and aortoesophageal fistulae
may lay in their etiology
Victor X. Mosquera, MD, PhD, A Coru~na, SpainAnnouncements The American Association for Thoracic Surgery3
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BE3263 AATS Cardiothoracic Surgery Resident Poster Competition)
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